+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
PTC Therapeutics - logo

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

Myostatin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Myostatin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Phenylketonuria - Pipeline Insight, 2024 - Product Thumbnail Image

Phenylketonuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 110 Pages
  • Global
From
Phenylketonuria - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Phenylketonuria - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • July 2023
  • 128 Pages
  • Global
From
Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • August 2023
  • 173 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2024 - Product Thumbnail Image

Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 152 Pages
  • Global
From
EPI-589 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPI-589 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030

  • Report
  • December 2021
  • 83 Pages
  • Global
From
Kaposi Sarcoma - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Kaposi Sarcoma - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 146 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 91 Pages
  • Global
From
Fibrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fibrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 73 Pages
  • Global
From
Comprehensive Report on PTC Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on PTC Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2024
  • 57 Pages
From
Loading Indicator